24Serious

Stuart Henry

Ask VT AI

View News Summary

Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
China's industrial profits surge in September, led by high-tech and equipment manufacturing, despite ongoing economic headwinds.
Russia tests nuclear-powered cruise missile, experts raise concerns over technical issues and contamination risks.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
China's industrial profits surge in September, led by high-tech and equipment manufacturing, despite ongoing economic headwinds.
Russia tests nuclear-powered cruise missile, experts raise concerns over technical issues and contamination risks.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Stuart Henry